In this article Alisha Mavis, MD, discusses the prevalence, diagnosis, challenges, and management of patients with this Alagille Syndrome, as well as the need for a multidisciplinary approach to care.
Information from Industry-Sponsored Content
Alagille Syndrome
Developed under the direction and sponsorship of Ipsen Biopharmaceuticals.
Next Article:
More News
- Does Bezlotoxumab Boost FMT Efficacy in IBD Patients With Recurrent CDI?
- Angiotensin Receptor Blockers May Lead to Worse Outcomes in Celiac Disease
- Common Crohn’s Immune Response to Gut Bacteria Suggests Therapeutic Target
- Liquid Fasting Mitigates Negative Pre-Surgery Impact of Semaglutide
- GLP-1 RAs Safe in the Perioperative Period: New Guidance
Question 1 of 5